Eventide Asset Management – SAREPTA THERAPEUTICS INC

Eventide Asset Management ownership history of SAREPTA THERAPEUTICS INC
QuarterValueSharesWeighting
Q1 2021$51,959
-67.3%
697,156
-25.2%
0.77%
-68.4%
Q4 2020$158,813
21.4%
931,5120.0%2.44%
-4.9%
Q3 2020$130,812
-18.1%
931,512
-6.5%
2.56%
-26.2%
Q2 2020$159,699
63.9%
996,0000.0%3.47%
10.0%
Q1 2020$97,429
-24.2%
996,0000.0%3.16%
-12.9%
Q4 2019$128,524
40.0%
996,000
-18.3%
3.62%
19.3%
Q3 2019$91,815
-46.2%
1,219,000
8.5%
3.03%
-41.5%
Q2 2019$170,640
69.4%
1,123,000
32.9%
5.19%
49.7%
Q1 2019$100,736
9.2%
845,1680.0%3.47%
-15.1%
Q4 2018$92,233
-7.9%
845,168
36.3%
4.08%
11.0%
Q3 2018$100,136
102.0%
620,000
65.3%
3.68%
78.8%
Q2 2018$49,568
196.0%
375,000
65.9%
2.06%
162.4%
Q1 2018$16,744
86.9%
226,000
40.4%
0.78%
67.9%
Q4 2017$8,958
22.7%
161,0000.0%0.47%
12.8%
Q3 2017$7,303
12.6%
161,000
-51.5%
0.41%
14.4%
Q1 2016$6,486
-49.4%
332,3000.0%0.36%
-43.5%
Q4 2015$12,820
22.3%
332,300
1.8%
0.64%
5.3%
Q3 2015$10,481
32.9%
326,400
26.0%
0.61%
42.6%
Q2 2015$7,884
129.1%
259,1000.0%0.43%
64.9%
Q1 2015$3,441
-8.2%
259,1000.0%0.26%
-36.7%
Q4 2014$3,749
-31.4%
259,1000.0%0.41%
-46.4%
Q3 2014$5,467
-29.2%
259,1000.0%0.76%
-27.3%
Q2 2014$7,719
24.0%
259,1000.0%1.05%
8.6%
Q1 2014$6,226
115.6%
259,100
82.7%
0.97%
8.7%
Q4 2013$2,888141,8000.89%